Are Probiotics Safe If You're Immunocompromised?

Medically written and reviewed by Dr Zeeshan Afzal, MBBS — General Practitioner. Last updated: 4 August 2026. This article is for general information and does not replace personalised advice from the clinician who manages your condition.

If you are living with a weakened immune system, the question of probiotics safety is not academic. Probiotic supplements are living organisms, and swallowing billions of live bacteria or yeast cells is a very different proposition when your body's defences are working normally versus when they are suppressed by chemotherapy, transplant medication, biologics or an inherited immune disorder. The short answer is that probiotics are not automatically unsafe if you are immunocompromised, but they are also not automatically safe — and the level of caution required depends enormously on why and how much your immunity is reduced. This guide walks through what the published evidence actually shows, which groups regulators and hospital dietitians advise to avoid live cultures altogether, and what the safer alternatives are. If you are new to this area, our overview of gut health in the UK and our explainer on the gut–immune system connection provide helpful background, and you can browse the full Welzo gut health range or our probiotics collection if you are comparing formats. Readers who are looking for non-live options often start with modified citrus pectin powder, Welzo Ultra Purity Berberine or Welzo Ultra Purity TUDCA, while those researching next-generation strains may be reading about Akkermansia muciniphila. It is also worth understanding how the gut barrier works and the general profile of probiotic side effects before you make a decision.

Table of contents

• The quick answer on probiotics safety
• What "immunocompromised" actually means
• How probiotics could cause harm when immunity is low
• What the evidence actually shows
• Who should avoid live probiotics
• Where supervised use may still be reasonable
• Probiotic safety in specific clinical situations
• Safer alternatives: prebiotics, postbiotics and food
• A practical safety checklist
• UK regulation and why it matters
• Red flags: when to seek medical help
• Frequently asked questions
• References

The quick answer on probiotics safety if you're immunocompromised

For most healthy adults, probiotics have an excellent safety record. The NHS states plainly that probiotics appear to be safe for most people and that, if you have a healthy immune system, they should not cause unpleasant side effects. The important qualifier in that sentence is the immune system.

When immunity is significantly impaired, the calculation changes. Live organisms that are harmless in the gut lumen can, in rare cases, cross into the bloodstream and cause bacteraemia (bacterial bloodstream infection) or fungaemia (fungal bloodstream infection). These events are rare in absolute terms, but they are concentrated almost entirely in people who were already seriously unwell, hospitalised, or profoundly immunosuppressed.

A reasonable summary of current practice looks like this:

• Avoid live probiotics if you are neutropenic, have a central venous catheter or line, are critically ill, have had a recent stem cell or organ transplant, or have severe acute pancreatitis.
• Only use with specialist approval if you are on chemotherapy, high-dose steroids, biologics, or have a primary immunodeficiency.
• Probably fine, but check first if your immunity is mildly reduced — for example well-controlled HIV with a normal CD4 count, or stable inflammatory bowel disease on maintenance therapy.

What "immunocompromised" actually means

"Immunocompromised" is an umbrella term covering a very wide range of severity. Treating it as a single category is the most common mistake people make when researching probiotics safety.

Primary (inherited) immunodeficiency

These are genetic conditions present from birth, such as common variable immunodeficiency (CVID), severe combined immunodeficiency (SCID), chronic granulomatous disease, or selective IgA deficiency. Severity ranges from near-normal life expectancy with minimal intervention to conditions requiring transplantation. Anyone with a defect in neutrophil function or T-cell immunity should treat live cultures as a specialist decision only.

Secondary (acquired) immunosuppression

This is by far the larger group and includes:

• Chemotherapy and radiotherapy for cancer
• Haematological malignancies such as leukaemia, lymphoma and myeloma
• Solid organ and stem cell transplant recipients on anti-rejection medication
• Biologic therapies for autoimmune disease — anti-TNF drugs, JAK inhibitors, rituximab
• Long-term corticosteroids (generally above 20 mg prednisolone daily for more than four weeks)
• Advanced or untreated HIV
• Asplenia or hyposplenism
• Advanced liver or kidney disease, and poorly controlled diabetes

Many of these conditions also disturb the gut microbial community itself. If you have been reading about gut dysbiosis or falling microbiome diversity after treatment, that concern is legitimate — it just does not automatically follow that a live supplement is the right correction.

Why severity, not label, drives the risk

The single most useful question is not "am I immunocompromised?" but "how impaired is my neutrophil count and how intact is my gut lining?" Two people can both be described as immunocompromised while sitting at completely different ends of the risk spectrum. A person with well-managed coeliac disease and a person on day seven after a bone marrow transplant require entirely different advice.

The two factors that matter most

• Neutrophil count. Neutropenia is the strongest single predictor of infection risk from any live organism.
• Gut barrier integrity. Chemotherapy-induced mucositis, severe colitis, recent bowel surgery and critical illness all create physical routes for organisms to translocate.

How probiotics could cause harm when immunity is low

There are five plausible mechanisms, and they are worth understanding because they explain exactly who is at risk and why.

1. Bacterial or fungal translocation

In a healthy person, the intestinal barrier and mucosal immune system keep gut organisms where they belong. Chemotherapy, radiotherapy, severe inflammation and critical illness all damage that barrier. A published narrative review of probiotics in intensive care notes that although probiotic-associated bacteraemia remains extremely rare, it is a genuine risk factor, particularly in hospitalised or immunocompromised patients. Our article on gut barrier function explains the underlying biology in more detail.

2. Central venous catheters and indwelling lines

Lines are a recurring theme in the case literature. Organisms can reach the bloodstream directly via a catheter hub, or via the hands of staff and family handling sachets near a line. A whole-genome-sequencing case report described bacteraemia caused by a Lacticaseibacillus rhamnosus strain given as a probiotic in a patient with a central venous catheter, with the blood isolate genetically matching the administered product.

3. Transfer of antibiotic resistance genes

The US National Center for Complementary and Integrative Health lists transfer of antibiotic resistance genes from probiotic microorganisms to other gut microbes as a recognised theoretical harm. This matters more in people who are likely to need repeated courses of antibiotics.

4. Product contamination and inaccurate labelling

Because probiotics are sold as food supplements rather than medicines in the UK, manufacturing standards vary. NCCIH notes that some probiotic products have been found to contain microorganisms other than those listed on the label, and that these contaminants may pose serious health risks. For an immunocompetent adult this is mostly a question of wasted money; for a neutropenic patient it is a safety issue. If you are evaluating products, our guides to how to choose a probiotic and CFU versus AFU counts cover what a credible label looks like.

5. Unwanted immune modulation

Some probiotic strains measurably shift cytokine profiles. In transplant recipients, where the entire therapeutic goal is controlled immune suppression, deliberately stimulating mucosal immunity is not obviously desirable. This remains theoretical rather than demonstrated, but it is a reason transplant teams are conservative.

What the evidence actually shows

Headlines in this area tend to be either reassuring or alarming, and both distort the picture. Here is what the primary literature says.

The large safety reviews are broadly reassuring

The most comprehensive synthesis remains the AHRQ evidence report on probiotic safety, produced by the RAND-based Southern California Evidence-based Practice Center. Its subgroup analyses of randomised trials in medium health-compromised participants and in critically ill patients did not show a statistically significant increase in adverse events compared with control groups. However, the same report concluded that the literature was not well equipped to answer safety questions with confidence, particularly in critically ill patients, and that the case reports of serious adverse events overwhelmingly involved health-compromised rather than healthy participants.

That combination — no signal in trials, but a consistent pattern in case reports — is exactly what you would expect for a rare, high-consequence event in a population that trials usually exclude.

Case reports show a consistent risk profile

A review of Lactobacillus bacteraemia found that it accounts for roughly 0.1–0.2% of all blood culture isolates from hospitalised patients and around 0.5% of blood isolates from immunocompromised patients. In one cohort of haematopoietic cell transplant recipients, the incidence was reported at 1.6 cases per 100,000 patient days. These are small numbers, but they are not zero, and they cluster in exactly the group this article is written for.

Saccharomyces boulardii has a formal regulatory restriction

This is the clearest regulatory line in the field. Following review of accumulated fungaemia reports, the European Medicines Agency concluded that the risk of using Saccharomyces boulardii-containing products in critically ill or immunocompromised patients outweighs the potential benefit, and that use in these groups should be contraindicated. Analysis published by the CDC in Emerging Infectious Diseases found that Saccharomyces fungaemias occurred most often in patients who had gastrointestinal tract disease.

If you have been considering this yeast for antibiotic-associated diarrhoea, read our dedicated page on Saccharomyces boulardii in the UK alongside this section, and discuss it with your team rather than self-prescribing.

The PROPATRIA trial changed the conversation

In 2008, the Dutch PROPATRIA trial randomised 298 patients with predicted severe acute pancreatitis to a multispecies probiotic preparation or placebo. The probiotic did not reduce infectious complications, and mortality was significantly higher in the probiotic group — 16% versus 6%. The authors concluded that probiotic prophylaxis should not be administered in this category of patients. The trial was later the subject of an expression of concern from The Lancet relating to its design, approval and conduct, but the core clinical caution stands: in patients with a severely compromised gut barrier, large doses of live organisms are not benign.

Putting the evidence together

Who should avoid live probiotics

Based on regulatory positions, UK hospital guidance and the case literature, live probiotic supplements are generally best avoided in the following situations unless a specialist has specifically recommended them.

Blood Cancer UK advises avoiding yoghurts and yoghurt drinks labelled probiotic or kefir during neutropenia unless a doctor or dietitian recommends them, noting that there is currently not enough evidence to say whether probiotic products are safe or beneficial for people with a weakened immune system. Ordinary live, bio, Greek and fruit yoghurts are considered safe. Macmillan Cancer Support gives comparable food safety advice for people whose immunity is very low.

Where supervised use may still be reasonable

Blanket avoidance is not always the right answer either. Several groups described as immunocompromised have participated in probiotic trials without a demonstrated excess of harm.

Well-controlled HIV

People on effective antiretroviral therapy with suppressed viral load and a normal CD4 count are, immunologically, closer to the general population than to a neutropenic patient. Probiotic use in this group is usually a straightforward conversation with the HIV team rather than a prohibition.

Stable inflammatory bowel disease

Certain formulations have an evidence base in ulcerative colitis specifically. If you are on maintenance therapy and in remission, the discussion is a real one — see our guides to the ulcerative colitis diet and the Crohn's disease diet in the UK. During a severe flare, or if you are on high-dose steroids or a biologic, the answer shifts towards caution.

Older adults with age-related immune decline

Immunosenescence is real but usually mild. Most healthy people in their seventies and eighties do not need to avoid probiotics, though the presence of multiple chronic conditions changes that. Our article on gut health in older adults covers this in more detail, as does our piece on gut health and ageing.

After a course of antibiotics

This is the most common reason people reach for probiotics, and the evidence for reducing antibiotic-associated diarrhoea is among the better parts of the field. If you are immunocompromised, however, this is precisely the scenario where Saccharomyces-based products carry the documented risk. Our articles on taking probiotics after antibiotics and probiotics for C. difficile discuss the trade-offs.

Probiotic safety in specific clinical situations

During chemotherapy

Chemotherapy causes both neutropenia and mucositis — the two risk factors that matter most. British Dietetic Association guidance for haematology patients notes that the gut lining acting as a barrier between bacteria and the bloodstream is damaged by chemotherapy and radiotherapy. Most UK oncology and haematology units therefore advise against probiotic-labelled products while counts are low. Whether this restriction applies between cycles, once counts recover, is a question for your own team.

Transplant recipients

Solid organ and stem cell transplant recipients sit in the highest-caution group, particularly in the first months after transplant when immunosuppression is heaviest and lines are often still in place. Anti-rejection medication is also prone to interactions, which is a separate reason to clear any supplement with the transplant pharmacist.

On biologics and immunosuppressants

Anti-TNF agents, JAK inhibitors, rituximab, methotrexate, azathioprine and mycophenolate all reduce immune competence to varying degrees. There is no formal contraindication to probiotics on these drugs, but there is also very little trial data. A pragmatic approach is to avoid yeast-based products, avoid very high-dose multi-strain formulations, and confirm with the prescribing team. Our overview of gut health and autoimmune conditions gives further context.

On long-term corticosteroids

Risk scales with dose and duration. Someone on a short reducing course for an asthma flare is in a different position from someone on 30 mg prednisolone daily for polymyalgia rheumatica over many months. Steroids also thin the gut mucosa and raise infection risk generally.

In hospital or intensive care

This is the highest-risk setting of all: lines, broad-spectrum antibiotics, damaged gut barriers, ventilation and severe illness combined. Probiotics in ICU should only ever be given as part of a supervised protocol, never brought in from home.

Pregnancy with immunosuppression

Probiotics are widely used in pregnancy and generally considered low risk, but immunosuppression changes the calculation. Our guide to probiotics in pregnancy is a starting point, with the caveat that obstetric and specialist input takes priority.

Children and infants

Neonatal probiotic use in preterm infants is a hospital-protocol matter with a specific evidence base, and NCCIH has noted reports of severe or fatal infections in premature infants given probiotics. Parents of immunocompromised children should not start products independently — see children's probiotics in the UK and baby probiotics for general information only.

Safer alternatives: prebiotics, postbiotics and food

If live cultures are off the table, you are not out of options. Most of what benefits the microbiome comes from feeding the bacteria you already have rather than adding new ones.

Prebiotic fibres

Prebiotics are non-living food ingredients — inulin, fructo-oligosaccharides, galacto-oligosaccharides, resistant starch, partially hydrolysed guar gum — that selectively feed beneficial resident bacteria. Because nothing live is introduced, the translocation risk does not apply. They can cause bloating, so start low. See our guides to the best prebiotic supplements in the UK, prebiotic foods and the difference between prebiotics and probiotics.

Postbiotics and heat-treated organisms

Postbiotics are inactivated microbes or their metabolites. Because the organisms are non-viable, they cannot colonise or translocate. This is an area of genuine interest for immunocompromised populations, although the clinical evidence base is still young. Pasteurised Akkermansia is one of the better-studied examples.

Fibre and dietary diversity

Plant diversity remains the most robust lever on microbiome composition, and it involves no live supplement at all. Our articles on eating 30 plants a week, increasing fibre intake and high-fibre foods in the UK set out practical approaches. Fibre fermentation also produces short-chain fatty acids, including butyrate, which supports the colonic lining directly.

Non-live gut lining support

Several supplements support mucosal integrity without introducing organisms, including zinc carnosine, collagen peptides and L-glutamine — our glutamine versus collagen comparison explains the differences. Butyrate supplements are another non-live option. All of these should still be cleared with your clinician, since immunosuppressive drug interactions matter more than the supplement itself.

Fermented foods

Fermented foods sit awkwardly in the middle. Standard live yoghurt is considered safe during neutropenia by UK hospital guidance; products marketed as probiotic, bio or kefir are the ones flagged for avoidance. Our page on fermented foods in the UK and the comparison of fermented food versus probiotics explain why the two categories are not interchangeable.

A practical safety checklist if your clinician says yes

Questions worth asking

• Is my neutrophil count currently in a safe range, and how often is it checked?
• Do I have any indwelling line, port or catheter?
• Is there a specific strain with evidence for my situation, rather than a generic blend?
• Could this interact with my immunosuppressive or anti-rejection medication?
• What symptoms should make me stop immediately?

Product quality checks

• Full strain designation on the label, not just genus and species
• Guaranteed count at end of shelf life rather than at manufacture — see CFU vs AFU
• Third-party testing for contaminants and identity verification
• Manufactured in a facility with recognised quality standards
• No unnecessary strain-stacking; fewer, better-evidenced strains are preferable in this context — see single vs multi-strain probiotics

Handling precautions if you are around a line

Case literature has implicated environmental contamination during sachet opening near central lines. Open capsules or sachets away from any line, wash hands before and after, and never prepare a probiotic drink at a bedside where a line is exposed.

Stop and seek advice if you develop

• Fever, rigors or shivering
• New or worsening abdominal pain
• Redness, pain or discharge around a line site
• Confusion, dizziness or feeling profoundly unwell
• Persistent diarrhoea or vomiting

If you are neutropenic and develop a fever, this is a medical emergency — contact your acute oncology or haematology line immediately rather than waiting.

UK regulation and why it matters here

In the UK, probiotics are almost always sold as food supplements, not medicines. They do not undergo the licensing, batch testing and pharmacovigilance that a medicine does. The NHS notes that because of the way probiotics are regulated, it is not always possible to be sure that a product contains the bacteria stated on the label, contains enough to have an effect, or that the organisms survive to reach the gut.

For a healthy adult, that uncertainty is mostly about efficacy. For an immunocompromised person, it also concerns identity and contamination. This is one of the few situations where the regulatory distinction has direct clinical consequences, and it is a strong argument for buying only from established suppliers with documented testing. Related reading: do probiotics actually work, do probiotics survive stomach acid, and the best probiotics in the UK.

Red flags: when to seek medical help

Regardless of whether you take probiotics, contact your clinical team urgently if you are immunocompromised and develop a temperature of 38°C or above, uncontrolled diarrhoea, blood in your stool, unexplained weight loss, or severe abdominal pain. Our guide on when to see a GP about stomach symptoms covers general thresholds, but immunosuppressed patients should always escalate sooner than the general advice suggests.

Frequently asked questions about probiotics safety

Are probiotics safe if you're immunocompromised?

It depends on the degree of immunosuppression. People with mild, well-controlled immune impairment can often take probiotics safely, while those who are neutropenic, critically ill, have central venous catheters, or are recent transplant recipients should avoid live probiotics unless a specialist has specifically recommended them. Always check with the team managing your condition first.

Can probiotics cause sepsis?

Very rarely, and almost exclusively in people who are already seriously unwell. Documented cases of probiotic-associated bacteraemia and fungaemia exist, and reviews describe sepsis, endocarditis and abscesses caused by probiotic strains, but these events are concentrated in hospitalised, critically ill or profoundly immunosuppressed patients rather than the general population.

Which probiotic strains are considered riskiest for immunocompromised people?

Saccharomyces boulardii carries a formal European regulatory contraindication in critically ill and immunocompromised patients because of fungaemia risk. Lacticaseibacillus rhamnosus features most often in bacteraemia case reports. This does not mean these strains are dangerous for healthy people — both have substantial evidence bases in the general population.

Can I eat yoghurt if I'm neutropenic?

UK hospital guidance generally permits ordinary live, bio, Greek, natural and fruit yoghurts during neutropenia, because the bacteria used in standard yoghurt manufacture are not considered harmful. Products specifically labelled probiotic or kefir are usually advised against unless your doctor or dietitian recommends them. Always follow your own unit's advice, as protocols vary.

Are probiotics safe during chemotherapy?

Most oncology teams advise against them while neutrophil counts are low, because chemotherapy damages the gut lining and reduces the white cells that would normally contain any organism entering the bloodstream. Between cycles, once counts have recovered, the position may be different — this is a decision for your oncology team, not a general rule.

Is it safe to take probiotics with a central line or PICC line?

This is one of the clearest cautions in the literature. Multiple case reports link probiotic administration to line-associated bloodstream infection, including cases confirmed by genetic matching between the blood isolate and the product. Most units advise avoiding probiotics entirely while a central line is in place.

Are prebiotics safer than probiotics if I'm immunosuppressed?

Generally yes, because prebiotics contain no live organisms and therefore cannot translocate or colonise. The main side effects are bloating and wind, which are usually manageable by starting at a low dose and increasing slowly. They are still worth mentioning to your clinician, particularly if you have IBS or a history of bowel obstruction.

Do postbiotics avoid the infection risk?

Postbiotics use inactivated microorganisms or their metabolites, so the infection risk associated with live cultures does not apply in the same way. The evidence base for clinical benefit is younger than for probiotics, but for immunocompromised users the safety profile is theoretically more favourable.

Should I stop probiotics before surgery or a transplant?

Yes, in almost all cases. Surgery, particularly abdominal surgery, disrupts the gut barrier, and transplant involves deliberate immunosuppression alongside indwelling lines. Tell your surgical and anaesthetic teams about every supplement you take, and expect to be advised to stop live cultures beforehand.

What should I do if I have already been taking probiotics and I'm immunocompromised?

Do not panic — serious adverse events are rare, and if you have been taking a product without problems, an urgent issue is unlikely. Stop taking it, note the exact product and strain, and raise it at your next appointment or sooner if you feel unwell. Seek urgent medical attention if you develop fever, rigors, severe abdominal pain, or symptoms around a line site.

References

1. NHS — Probiotics
2. National Center for Complementary and Integrative Health — Probiotics: Usefulness and Safety
3. AHRQ Evidence Report No. 200 — Safety of Probiotics to Reduce Risk and Prevent or Treat Disease (Executive Summary)
4. Besselink MG et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet, 2008
5. Expression of concern — Probiotic prophylaxis in predicted severe acute pancreatitis. The Lancet, 2010
6. European Medicines Agency — Saccharomyces boulardii: CMDh scientific conclusions and grounds for variation
7. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements. Emerging Infectious Diseases (CDC), 2021
8. Lactobacillus Bacteremia and Probiotics: A Review. Microorganisms, 2023
9. Probiotics: Should All Patients Take Them? Microorganisms, 2021
10. Merenstein D et al. Emerging issues in probiotic safety: 2023 perspectives. Gut Microbes, 2023
11. Bacteraemia caused by Lactobacillus rhamnosus given as a probiotic in a patient with a central venous catheter: a WGS case report
12. Recurrent Lactobacillus rhamnosus bacteraemia and complications in an immunocompromised patient with history of probiotic use. Cureus, 2024
13. Blood Cancer UK — Eating safely with neutropenia
14. British Dietetic Association — Safer eating with neutropenia, for haematology patients
15. Macmillan Cancer Support — Food safety when your immunity is low
16. Probiotic treatment in an intensive care unit: a narrative review, 2025

About the author

Dr Zeeshan Afzal, MBBS is a General Medical Council-registered doctor working in general practice in the UK, with a clinical interest in digestive health, preventive medicine and evidence-based use of supplements. He writes and medically reviews content for Welzo.

Medical disclaimer

This article is intended for general information only and is not a substitute for individual medical advice. Probiotic decisions in immunocompromised patients are highly individual and should be made with the clinician or specialist team responsible for your care. If you are immunocompromised and develop a fever or feel acutely unwell, seek urgent medical attention. In an emergency in the UK, call 999 or attend your nearest emergency department; for urgent but non-emergency advice, call NHS 111.